CC
Clearline Capital Portfolio holdings
AUM
$1.14B
This Quarter Return
+2.69%
1 Year Return
-2.59%
3 Year Return
+9.29%
5 Year Return
+19.13%
10 Year Return
-36.67%
AUM
$1.13B
AUM Growth
+$1.13B
(-1.1%)
Cap. Flow
-$59.2M
Cap. Flow
% of AUM
-5.24%
Top 10 Holdings %
Top 10 Hldgs %
29.09%
Holding
177
New
33
Increased
40
Reduced
37
Closed
36
Top Buys
| 1 |
Golar LNG
GLNG
|
$36.9M |
| 2 |
NVIDIA
NVDA
|
$32.9M |
| 3 |
Hewlett Packard
HPE
|
$24.6M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$22.5M |
| 5 |
Masimo
MASI
|
$21.3M |
Top Sells
| 1 |
Teladoc Health
TDOC
|
$35.3M |
| 2 |
Apple
AAPL
|
$31.5M |
| 3 |
Kenvue
KVUE
|
$27.7M |
| 4 |
TKO Group
TKO
|
$27M |
| 5 |
Semtech
SMTC
|
$20.8M |
Sector Composition
| 1 | Technology | 31.13% |
| 2 | Healthcare | 19.77% |
| 3 | Consumer Discretionary | 17.65% |
| 4 | Communication Services | 12.51% |
| 5 | Energy | 4.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Crown Holdings
CCK
$10.7B
| $1.83M | 0.08% |
19,087
-135,368
| -88% | -$13M |
|
102
Coterra Energy
CTRA
$18.4B
| $1.82M | 0.08% |
+75,970
| New | +$1.82M |
|
|
MAGN
103
Magnera Corporation
MAGN
$413M
| $1.78M | 0.08% |
989,463
+284,731
| +40% | +$513K |
|
|
ITOS
104
DELISTED
iTeos Therapeutics
ITOS
| $1.71M | 0.07% |
167,417
+10,523
| +7% | +$107K |
|
105
Maravai LifeSciences
MRVI
$341M
| $1.57M | 0.07% |
+189,239
| New | +$1.57M |
|
106
Viatris
VTRS
$12.3B
| $1.53M | 0.07% |
131,941
| – | – |
|
|
GRAL
107
GRAIL, Inc. Common Stock
GRAL
$1.17B
| $1.45M | 0.06% |
105,685
-119,698
| -53% | -$1.65M |
|
108
Bloomin' Brands
BLMN
$595M
| $1.33M | 0.06% |
80,320
| – | – |
|
109
Tenable Holdings
TENB
$3.72B
| $1.15M | 0.05% |
+28,357
| New | +$1.15M |
|
|
ZUO
110
DELISTED
Zuora, Inc.
ZUO
| $1.11M | 0.05% |
+128,984
| New | +$1.11M |
|
111
Opko Health
OPK
$1.1B
| $1.08M | 0.05% |
+726,582
| New | +$1.08M |
|
112
TherapeuticsMD
TXMD
$12.7M
| $1.06M | 0.04% |
636,622
| – | – |
|
113
Dollar Tree
DLTR
$21.3B
| $1.05M | 0.04% |
+14,910
| New | +$1.05M |
|
114
FIVE9
FIVN
$2.05B
| $1.05M | 0.04% |
36,413
| – | – |
|
115
Nuvation Bio
NUVB
$1.08B
| $999K | 0.04% |
436,437
-800
| -0.2% | -$1.83K |
|
116
Diebold Nixdorf
DBD
$2.19B
| $948K | 0.04% |
21,228
-14,622
| -41% | -$653K |
|
117
CommScope
COMM
$3.57B
| $924K | 0.04% |
151,177
-107,860
| -42% | -$659K |
|
118
NCR Atleos
NATL
$2.87B
| $921K | 0.04% |
32,299
-274,438
| -89% | -$7.83M |
|
119
Informatica
INFA
$7.6B
| $917K | 0.04% |
+36,262
| New | +$917K |
|
120
Olo Inc
OLO
$1.74B
| $842K | 0.04% |
169,737
| – | – |
|
121
Freshworks
FRSH
$3.81B
| $828K | 0.04% |
72,149
| – | – |
|
122
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $816K | 0.03% |
784,449
| – | – |
|
123
Syndax Pharmaceuticals
SNDX
$1.39B
| $812K | 0.03% |
42,195
| – | – |
|
124
LENSAR
LNSR
$144M
| $792K | 0.03% |
173,004
| – | – |
|
125
Enhabit
EHAB
$398M
| $774K | 0.03% |
97,923
| – | – |
|